Kok-Seong Lim | Independent Expert
Independent Expert

Kok-Seong Lim, BPharm, PhD, is a pharmaceutical leader with over 20 years of experience in biological research and development, specializing in analytical sciences, quality control, and CMC strategy for advanced therapy platforms. He has held management roles at Metagenomi, Aura Biosciences, Editas Medicine and Thermo Fisher Scientific. In these roles, he supported the development of more than 10 gene therapies and CRISPR-based medicines across rare disease and oncology. His work includes building GMP-compliant facilities and analytical infrastructures to support early- and late-stage development. He has contributed to regulatory submissions in both the U.S. and EU. An active industry contributor, Kok-Seong presents regularly at conferences and serves as Chair of the RAPS San Francisco Chapter and as a member of the U.S. Pharmacopeia Biologics - Cell and Gene Therapy Expert Committee where he contributes to the development of industry standards and best practices for cell and gene therapy. He earned his PhD in Biochemistry from the National University of Singapore and a BSc in Pharmacy from the University of Strathclyde.